Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Valproate (valproic acid, VPA, sodium valproate, or valproate semisodium) is a medication primarily used to treat epilepsy and as a mood stabilizer in the treatment of bipolar disorder. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. It can be given intravenously or by mouth, and the…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Valproate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
acid valproic also sodium may include drug effects concentrations epilepsy women tablets bipolar united metabolism liver abbott disorder known men
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Valproate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Valproate | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Valproate | ATC code | N03AG01 (WHO) | 1.00 | infobox |
| Valproate | Bioavailability | ~90% | 1.00 | infobox |
| Valproate | CAS Number | 99-66-1 Y | 1.00 | infobox |
| Valproate | ChEBI | CHEBI:39867 Y | 1.00 | infobox |
| Valproate | ChEMBL | ChEMBL109 Y | 1.00 | infobox |
| Valproate | ChemSpider | 3009 Y | 1.00 | infobox |
| Valproate | CompTox Dashboard (EPA) | DTXSID6023733 | 1.00 | infobox |
| Valproate | Drug class | Anticonvulsant; Mood stabilizer; Sodium channel blocker; GABA-T inhibitor; Histone deacetylase inhibitor | 1.00 | infobox |
| Valproate | DrugBank | DB00313 Y | 1.00 | infobox |
| Valproate | ECHA InfoCard | 100.002.525 | 1.00 | infobox |
| Valproate | Elimination half-life | 9–16 hours | 1.00 | infobox |
| Valproate | Excretion | Mostly via hepatic metabolism, <3% in urine | 1.00 | infobox |
| Valproate | Formula | C8H16O2 | 1.00 | infobox |
| Valproate | IUPHAR/BPS | 7009 | 1.00 | infobox |
| Valproate | KEGG | D00399 Y | 1.00 | infobox |
| Valproate | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Valproate | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Valproate | Legal status | CA: ℞-only | 1.00 | infobox |
| Valproate | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Valproate | Legal status | US: ℞-only | 1.00 | infobox |
| Valproate | License data | US DailyMed: Valproic acid | 1.00 | infobox |
| Valproate | MedlinePlus | a682412 | 1.00 | infobox |
| Valproate | Metabolism | Liver—glucuronide conjugation 30–50%; mitochondrial β-oxidation over 40%; oxidation, hydroxylation, and dehydrogenation 15–20% | 1.00 | infobox |
| Valproate | Molar mass | 144.214 g·mol−1 | 1.00 | infobox |
| Valproate | NIAID ChemDB | 057177 | 1.00 | infobox |
| Valproate | Other names | VPA; valproic acid; sodium valproate (sodium); valproate semisodium (semisodium); 2-propylvaleric acid | 1.00 | infobox |
| Valproate | Pregnancy category | AU: D | 1.00 | infobox |
| Valproate | Protein binding | 80–90% | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.